Last Updated:
Access Report
Name Designation Appointment Date Status
Pritiben Maheshbhai Thaker

Appointed as Designated Partner since December 2020

 Designated Partner 31-Dec-2020 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Urmi Jayeshkumar Pandya

Appointed as Designated Partner since December 2020

 Designated Partner 31-Dec-2020 Current

People Timeline

Explore the timeline of key personnel in Urvas Pharmaceuticals Llp's leadership journey.

Contact Details
  • Address C 204, Valkeshwar Society, R. Nilkanth Mahadev, Opp. Kalakunj Society, Ranna Park, Ahmedabad Gujarat, 380061, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 380061
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Urvas Pharmaceuticals Llp?
You can contact Urvas Pharmaceuticals Llp through their registered address at C 204, Valkeshwar Society, R. Nilkanth Mahadev, Opp. Kalakunj Society, Ranna Park, Ahmedabad Gujarat, 380061, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Urvas Pharmaceuticals Llp?
The current directors of Urvas Pharmaceuticals Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PRITIBEN MAHESHBHAI THAKER
  • URMI JAYESHKUMAR PANDYA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available